Centerspace Valuation
Is WXC1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of WXC1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: WXC1 (€50) wird unter unserer Schätzung des Fair Value (€83.4) gehandelt.
Deutlich unter dem Marktwert: WXC1 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for WXC1?
Other financial metrics that can be useful for relative valuation.
What is WXC1's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$882.79m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.9x |
Enterprise Value/EBITDA | 16.3x |
PEG Ratio | -0.3x |
Price to Earnings Ratio vs Peers
How does WXC1's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 15.1x | ||
NXRT NexPoint Residential Trust | 18.3x | -57.8% | US$811.3m |
ESP Empiric Student Property | 10.3x | 17.9% | UK£551.5m |
MRG.UN Morguard North American Residential Real Estate Investment Trust | 3.4x | n/a | CA$863.2m |
INA Ingenia Communities Group | 28.3x | 15.9% | AU$2.1b |
WXC1 Centerspace | 23.9x | -83.3% | €882.8m |
Price-To-Earnings gegen Gleichaltrige: WXC1 ist auf der Grundlage des Price-To-Earnings Verhältnisses (24x) im Vergleich zum Durchschnitt der Vergleichsgruppe (-195.8x) teuer.
Price to Earnings Ratio vs Industry
How does WXC1's PE Ratio compare vs other companies in the Global Residential REITs Industry?
Price-To-Earnings gegen Industrie: WXC1 ist teuer, wenn man sein Price-To-Earnings Verhältnis (23.7x) mit dem Global Residential REITs Branchendurchschnitt (23x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is WXC1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 23.9x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von WXC1 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | €51.50 | €58.42 +13.4% | 5.4% | €64.24 | €54.93 | n/a | 8 |
Mar ’25 | €51.50 | €57.65 +11.9% | 5.9% | €63.77 | €52.68 | n/a | 8 |
Feb ’25 | €50.50 | €56.39 +11.7% | 5.9% | €63.01 | €52.05 | n/a | 8 |
Jan ’25 | €53.00 | €55.89 +5.5% | 6.2% | €63.09 | €52.12 | n/a | 8 |
Dec ’24 | €49.80 | €54.80 +10.0% | 7.1% | €62.89 | €51.04 | n/a | 8 |
Nov ’24 | €45.00 | €59.65 +32.5% | 6.9% | €65.20 | €52.91 | n/a | 8 |
Oct ’24 | €57.00 | €65.15 +14.3% | 4.3% | €70.82 | €61.37 | n/a | 8 |
Sep ’24 | €59.00 | €63.22 +7.2% | 4.8% | €69.15 | €59.93 | n/a | 7 |
Aug ’24 | €60.00 | €62.04 +3.4% | 5.7% | €68.29 | €56.45 | n/a | 7 |
Jul ’24 | €55.50 | €60.46 +8.9% | 5.2% | €63.99 | €56.67 | n/a | 7 |
Jun ’24 | €54.50 | €61.11 +12.1% | 5.1% | €65.10 | €57.66 | n/a | 7 |
May ’24 | €50.50 | €58.86 +16.5% | 5.2% | €62.89 | €54.69 | n/a | 7 |
Apr ’24 | €49.80 | €62.18 +24.9% | 3.0% | €65.00 | €59.35 | €52.50 | 7 |
Mar ’24 | €57.50 | €63.97 +11.3% | 5.0% | €70.70 | €59.39 | €51.50 | 7 |
Feb ’24 | €62.50 | €66.63 +6.6% | 6.6% | €73.59 | €60.71 | €50.50 | 7 |
Jan ’24 | €55.00 | €68.19 +24.0% | 6.1% | €74.88 | €61.78 | €53.00 | 7 |
Dec ’23 | €62.00 | €70.73 +14.1% | 5.0% | €76.91 | €66.34 | €49.80 | 7 |
Nov ’23 | €67.50 | €83.02 +23.0% | 13.2% | €101.24 | €69.86 | €45.00 | 7 |
Oct ’23 | €68.50 | €92.99 +35.8% | 8.0% | €102.03 | €78.56 | €57.00 | 7 |
Sep ’23 | €76.50 | €93.79 +22.6% | 4.2% | €99.62 | €85.67 | €59.00 | 7 |
Aug ’23 | €83.00 | €92.23 +11.1% | 6.6% | €103.16 | €80.57 | €60.00 | 8 |
Jul ’23 | €78.50 | €89.78 +14.4% | 6.9% | €99.75 | €77.90 | €55.50 | 8 |
Jun ’23 | €79.00 | €96.09 +21.6% | 5.5% | €102.50 | €85.73 | €54.50 | 8 |
May ’23 | €87.50 | €102.46 +17.1% | 5.0% | €113.54 | €96.00 | €50.50 | 8 |
Apr ’23 | €92.00 | €101.01 +9.8% | 5.4% | €111.18 | €94.91 | €49.80 | 8 |
Analysten-Prognose: Das Kursziel liegt weniger als 20% über dem aktuellen Aktienkurs.